OPKO Health press release (OPK): Q2 GAAP EPS of -$0.01 beats by $0.07. – Revenue of $163.5M (+4.3% Y/Y) beats by $32.27M. – Cash, cash equivalents, marketable securities and restricted cash: Cash, cash equivalents, marketable securities and restricted cash were $314.4 million as…
June 30, 2026. As of June